Skip to main content

Trauma clinical trials at UC Irvine

3 in progress, 1 open to eligible people

Showing trials for
  • Onyx™ Liquid Embolic IDE Clinical Study

    open to eligible people ages 22 years and up

    The purpose of this study is to evaluate the safety and effectiveness of Onyx™ LES in the treatment of subjects with active arterial bleeding in the peripheral vasculature outside of the heart and brain.

    Irvine, California and other locations

  • Humacyte Human Acellular Vessel (HAV) in Patients With Vascular Trauma

    Sorry, in progress, not accepting new patients

    This study evaluates the use of the Human Acellular Vessel (HAV) in adults with vascular trauma below the neck who are undergoing vascular reconstructive surgery. There will be a torso cohort and a limb cohort. All subjects will be implanted with a HAV as an interposition vessel or bypass using standard vascular surgical techniques. There is no control arm.

    Orange, California and other locations

  • Induction Medications Used in the Trauma RSI

    Sorry, not yet accepting patients

    To compare the outcomes of the use of propofol, etomidate, and ketamine as induction agents for adult trauma patients undergoing intubation within 24 hours of admission. The primary goal is to determine the ideal agent that should be used in this patient population for intubations.

    Los Angeles, California